Two new photoluminescent compounds with the formulas of [Eu(2)(adipate)(3)(H(2)O)].H(2)O (1) and [Eu(2)(adipate)(3)(4H(2)O)] (2) were synthesized by using Eu(III) chloride and adipic acid under hydrothermal reaction conditions in aqueous solution. Compound 1, a 3-D layered framework, possesses infinite Eu-O-Eu polyhedral chains and self-assembled adipate ligands between Eu-O layers. Compound 2 has dimeric Eu(2)O(16) units interconnected by adipate ligand, resulting in 2-D open frameworks with a cavity among the ligands. Crystal data 1: monoclinic space group C2/c, with a = 14.2486(12) A, b = 8.2733(7) A, c = 39.298(2) A, beta = 99.530(6) degrees, and Z = 8. 2: monoclinic space group P2(1)/c, with a = 11.661(4) A, b = 14.011(3) A, c = 9.013(4) A, beta = 110.87(3) degrees, and Z = 2. The ligand conformations of two Eu(III)-adipate (1 and 2) compounds present anti/anti/anti, gauche/anti/gauche, and intermediate forms. Both compounds 1 and 2 showed strong red luminescence upon excitation, and their luminescence decay involves the multiphonon relaxation mechanism.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: